NCT00456443|Completed
Loading search results
Sponsor study identifier
observational
200
1 country
1
Study Start
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
June 2006
Actual (reported)Patients diagnosed as having hemoglobinopathies are exposed to serious bacterial infections, principally those patients that underwent splenectomy. Since the introduction of anti pneumococcal vaccine the incidence decreased significantly but other bacteria besides encapsulated bacteria takes place as principal cause of invasive infections. The purpose of this study is to analyse in a retrospective study the incidence of those infections in a group of patients suffering from thalassemia and sickle cell anemia treated in our clinic.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
June 2006
Actual (reported)April 4, 2007
Actual (reported)April 5, 2007
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, 18101, Israel
Ariel Koren, MD
Pediatric Hematology Unit, Ha'Emek Medical Center
Waheeb Sakran, MD
Pediatric Dpt B - Ha'Emek Medical Center
First Submitted
April 4, 2007
First Posted
April 5, 2007
Study Start
January 2006
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
June 2006
Actual (reported)L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Last Updated
April 5, 2007
Record last verified: 2007-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: